The report entitled The Plasma Proteins Market in the Middle East 2019 provides sales in units and dollars of all the therapeutic plasma and recombinant proteins by company for 18 total countries. It covers complete historical sales of 2019 and some events in early 2020 was completed in the fall of 2020. These countries included are:

Algeria, Bahrain, Egypt, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, South Arica, Syria, Tunisia, Turkey, United Arab Emirates and Yemen.

This report is updated every three years and has historical data from 2013 and 2016 for analyzing recent growth trajectories.

As in previous reports, the sales data in this region largely reflect the results of public tenders, and in a few countries sales on a generally modest private market. The report also analyses products distribution and pricing, blood and plasma collections, plasma fractionation, hemophilia care and new product introductions.

The report is delivered electronically (Excel and pdf files) and as a hard copy. Each country chapter covers the topics listed in the table of contents of a sample country chapter below.

For more information or to order this report, please contact
The Marketing Research Bureau at info@marketingresearchbureau.com, or +1 425 502 6265.


 

THE PLASMA PROTEINS MARKET IN THE MIDDLE EAST
2019

 

TABLE OF CONTENTS OF A SAMPLE COUNTRY CHAPTER

EXECUTIVE SUMMARY
HEALTH CARE ENVIRONMENT
BLOOD AND PLASMA COLLECTIONS
PLASMA FRACTIONATION
MARKET OVERVIEW
INTRAMUSCULAR IMMUNE GLOBULIN MARKET

Polyvalent Intramuscular & Subcutaneous Immune Globulin
Tetanus Immune Globulin
Rho(D) Immune Globulin
Rabies immune Globulin
Hepatitis B Immune Globulin
Other Hyperimmune Globulin

IVIG & SCIG MARKET
ALBUMIN MARKET
HEMOPHILIA CARE MARKET

Demographic Data on Hemophilia
Hemophilia Care Delivery
Factor VIII (Plasma derived, recombinant and non-factors (Hemlibra)
Factor IX (Plasma derived and recombinant products)
von Willebrand Factor
Inhibitor Care Market

OTHER PLASMA PRODUCTS MARKETS

Alpha-1 Antitrypsin
Antithrombin III
C1-Esterase Inhibitor
Fibrinogen
Fibrin Sealant

Other Products

REGISTRATION AND REGULATIONS
PRICING AND DISTRIBUTION
MARKET TRENDS AND THREE YEAR FORECAST
LIST OF MAJOR COMPANIES AND ORGANIZATIONS